Bacterial heat shock protein genes during induction chemotherapy in pediatric patients with acute lymphoblastic

Katherine A Dunn1,2,3, Emma MacDonald1, Tamara MacDonald4,5

  • 1Department of Pediatrics, Division of Hematology Oncology, Izaak Walton Killam (IWK) Health, Halifax, NS, Canada.

PubMed

Insights

Pediatric leukemia patients undergoing treatment showed changes in bacterial heat shock protein (HSP) genes within their gut microbiome. Specific HSP genes and microbial communities shifted during treatment, suggesting a link between gut bacteria and cancer progression.

Area of Science:

  • Microbiology
  • Oncology
  • Genetics

Background:

  • Heat shock proteins (HSP) are known to protect cancer cells.
  • Gastrointestinal bacteria possess HSP genes and can release extracellular vesicles.
  • Treatment-induced stress may alter the gut microbiome, potentially increasing HSP gene abundance and contributing to circulating HSP levels.

Purpose of the Study:

  • To investigate the abundance of bacterial heat shock protein (HSP) genes in pediatric acute lymphoblastic leukemia (ALL) patients.
  • To analyze changes in these HSP genes and the gut microbial community composition during cancer treatment.

Main Methods:

  • Analysis of five bacterial HSP genes in stool samples from 30 pediatric ALL patients.
  • Comparison of HSP gene abundance and microbial community diversity pre-treatment and during treatment induction.

Main Results:

  • A significant decrease in mean HTPG counts was observed pre-treatment versus during induction (p=0.0024).
  • During induction, HTPG, Shannon diversity, and Bacteroidetes decreased (p=7.5e-4; 1.1e-3; 8.6e-4).
  • Conversely, DNAK and Firmicutes showed an increase during induction (p=6.9e-3; 9.2e-4).

Conclusions:

  • Changes in the gut microbial HSP gene community during leukemia treatment were identified.
  • Further research is needed to determine the role of bacterial HSPs in the tumor microenvironment and their impact on leukemia treatment efficacy.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
Other Stress Responses in Bacteria01:30

Other Stress Responses in Bacteria

Bacteria have global regulatory systems that control several types of stress mechanisms. These include Pho regulon and the heat shock response, which are essential systems for environmental adaptation, such as nutrient limitation and proteotoxic stress. The Pho regulon and the heat shock response exemplify bacterial resilience, enabling rapid adaptation to fluctuating environmental conditions.Pho RegulonBacteria require phosphorus for essential cellular processes, including nucleic acid...